--- title: "AIBOTICS, INC. (AIBT) news: merger" url: "https://aibio.space/companies/aibotics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "AIBT merger news: Aibotics agrees to acquire Empulser for Series C preferred stock. AIBOTICS, INC. (OTC: AIBT), United States." --- AIBT AIBOTICS, INC. OTC · United States # AIBOTICS, INC. (AIBT) news AIBT merger news Mergers · 2026-10-14 ## [Aibotics completes purchase of PlayJamaica robotics and drone assets](https://aibio.space/news/aibotics-completes-purchase-playjamaica-robotics-drone-assets/) Aibotics signed an asset purchase agreement with PlayJamaica Limited on October 12, 2026, and completed the acquisition on October 14, issuing 22,500 shares of Series B Preferred Stock. ## Latest AIBOTICS, INC. news 1. 2026-10-02 Company Updates [Aibotics agrees to acquire Empulser for Series C preferred stock](https://aibio.space/news/aibotics-agrees-acquire-empulser-series-c-preferred-stock/) The October 2, 2026 exchange agreement would give Aibotics all membership interests in Empulser Enterprises LLC in return for Series C Preferred Stock with a stated value of up to $22,000,000. ## AIBOTICS, INC. at a glance - **Ticker**: AIBT - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $233,427 ### Related companies - [EBR Systems](https://aibio.space/companies/ebr-systems/) OTC: EBRCZ - [Nuwellis](https://aibio.space/companies/nuwellis/) NASDAQ: NUWE - [STAAR SURGICAL CO](https://aibio.space/companies/staar-surgical/) NASDAQ: STAA - [TELA Bio](https://aibio.space/companies/tela-bio/) NASDAQ: TELA - [Cannabis Bioscience International Holdings](https://aibio.space/companies/cannabis-bioscience-international/) OTC: CBIH - [ILLUMINA, INC.](https://aibio.space/companies/illumina/) NASDAQ: ILMN - [Bausch & Lomb](https://aibio.space/companies/bausch-lomb/) NYSE: BLCO - [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC ### Also on OTC - [Beroni Group](https://aibio.space/companies/beroni/) BNIGF - [Mosaic ImmunoEngineering](https://aibio.space/companies/mosaic-immunoengineering/) CPMV - [NOVACCESS GLOBAL INC.](https://aibio.space/companies/novaccess-global/) XSNX - [PONIARD PHARMACEUT](https://aibio.space/companies/poniard-pharmaceut/) PARD - [LogicMark](https://aibio.space/companies/logicmark/) LGMK - [Evelo Biosciences](https://aibio.space/companies/evelo-biosciences/) EVLO ## AIBOTICS, INC. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2,183](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | [$0](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | | Net income (loss) | [-$2.2 million](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | [-$1.8 million](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | | Cash from operations | [-$458,240](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | [-$259,037](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/) | | Cash and equivalents | [$255,940](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001264/) | [$185,097](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001264/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $233,427. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about AIBOTICS, INC. Is AIBOTICS, INC. involved in a merger or acquisition? Our latest story on this, dated Oct 2, 2026: "Aibotics agrees to acquire Empulser for Series C preferred stock". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/aibotics-agrees-acquire-empulser-series-c-preferred-stock/). What is the ticker symbol of AIBOTICS, INC.? AIBOTICS, INC. trades under the ticker AIBT on OTC. Where is AIBOTICS, INC. listed? AIBOTICS, INC. is listed on OTC. Which country or territory is AIBOTICS, INC. listed under? Our directory records AIBOTICS, INC. under United States. Does aibio.space cover AIBOTICS, INC.? aibio.space lists AIBOTICS, INC. among 2,820 public biotech companies and publishes its news here as stories appear. What was AIBOTICS, INC.'s revenue last year? $2,183 for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is AIBOTICS, INC. profitable? AIBOTICS, INC. reported a net loss of $2.2 million for the fiscal year ended Dec 31, 2025, and used $458,240 of cash in operations, per its annual report to the SEC. How much cash does AIBOTICS, INC. have? $233,427 in cash at Jun 30, 2026, per its 10-Q. What is the latest AIBOTICS, INC. (AIBT) stock news? Our latest story on AIBOTICS, INC., dated Oct 14, 2026: "Aibotics completes purchase of PlayJamaica robotics and drone assets". Aibotics signed an asset purchase agreement with PlayJamaica Limited on October 12, 2026, and completed the acquisition on October 14, issuing 22,500 shares of Series B Preferred Stock. [Source](https://aibio.space/news/aibotics-completes-purchase-playjamaica-robotics-drone-assets/). How can I follow AIBOTICS, INC. (AIBT) news? Press Follow on this page to add AIBOTICS, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming AIBOTICS, INC. so far, in Company Updates, Mergers. ## Investor discussion: AIBOTICS, INC. Members talk about AIBOTICS, INC. (AIBT). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at AIBOTICS, INC., newest first. Each line links the filing it comes from. 1. 2026-10-16 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001565/aibt-20261014_8k.htm) 2. 2026-08-14 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001231/aibt_nt10q.htm) 3. 2026-05-15 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000810/aibt_nt10q.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:AIBT on TradingView](https://www.tradingview.com/symbols/OTC-AIBT/). ## Listing details AIBOTICS, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker AIBT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: AIBOTICS, INC. - **Ticker**: AIBT - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/aibotics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "AIBOTICS, INC. (AIBT) news: merger", 2026-10-31, https://aibio.space/companies/aibotics/